companiesandmarkets.com

Return to Report | Print

Jazz Pharmaceuticals Inc - Corporate and Strategic Assessment Report - Company Strategy, SWOT Analysis

http://www.companiesandmarkets.com/Summary-Company-Profile/jazz-pharmaceuticals-inc-corporate-and-strategic-assessment-report-company-strategy,-swot-analysis-45966.asp

Report Summary

Introduction

Jazz Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. The company's product portfolio includes three marketed products, namely, Xyrem, Luvox CR and Antizol.

Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


    • Highlights

    The company's product portfolio include Xyrem, for the treatment of cataplexy and excessive daytime sleepiness in patients with narcolepsy; Luvox CR, for the treatment of obsessive compulsive disorder social anxiety disorder; and Antizol, for the treatment of ethylene glycol and methanol poisoning.

    Its product pipeline comprises JZP-6, the company's lead candidate undergoing Phase III trials for the treatment of fibromyalgia syndrome and Phase II programs in recurrent acute repetitive seizures (JZP-8), epilepsy bipolar disorder (JZP-4) and restless legs syndrome (JZP-7).

    Jazz Pharmaceuticals' major contributor to the total sales growth out to 2010 will be the revenues from the product sales of Luvox CR. Luvox CR product revenues are expected to increase from $42 million in 2008 (year of launch) to $166 million in 2010.

    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

    • Table of Contents

    TABLE OF CONTENTS
    Overview 1
    Catalyst 1
    Summary 1
    Company Structure 7
    Company Overview and Key Facts 7
    Business Description 8
    History 9
    Company Financials 11
    P&L 11
    Balance Sheet 14
    Cash Flow 14
    Business Segment Performance 15
    Geographic Segment Performance 17
    Products & Services 18
    Marketed Products 18
    Pipeline Products 19
    Historical Product Sales 21
    AC Forecast Product Sales 22
    Competitors and Strategic Business Relationships 24
    Top Competitors 24
    Key Suppliers 25
    Key Clients 25
    Shareholding Structure 26
    Strategy 27
    Corporate Strategy 27
    SWOT Analysis 29
    Overview 29
    Strengths 30
    Weaknesses 31
    Opportunities 32
    Threats 33
    Value Chain Analysis 34
    Overview 34
    Discovery and Product Development 35
    Sales 35
    Scorecard 36
    Overview 36
    Scorecard Analysis 37
    Key Employees 38
    List of Key Employees 38
    Key Employee Biographies 39
    Financial and Operational Overview 47
    Financial and Operational Overview 47
    Appendix 49
    Ask the analyst 49
    Datamonitor consulting 49
    Disclaimer 49


    TABLE OF FIGURES
    Figure 1: Jazz Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 12
    Figure 2: Jazz Pharmaceuticals – Key Strategic Revenues, 2002-2006 ($ Mn) 16
    Figure 3: Jazz Pharmaceuticals – Key Strategic Revenues, 2006-2010 ($ Mn) 23


    TABLE OF TABLES
    Table 1: Jazz Pharmaceuticals - Key Facts 7
    Table 2: Jazz Pharmaceuticals - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 11
    Table 3: Jazz Pharmaceuticals - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 13
    Table 4: Jazz Pharmaceuticals - Balance Sheet, 2002-2006 ($ Mn) 14
    Table 5: Jazz Pharmaceuticals - Balance Sheet, 2002-2006 ($ Mn) 14
    Table 6: Jazz Pharmaceuticals - Revenue Breakdown, 2002-2006 ($ Mn) 15
    Table 7: Jazz Pharmaceuticals - Geographic Breakdown, 2002-2006 ($ Mn) 17
    Table 8: Jazz Pharmaceuticals – Marketed Products 18
    Table 9: Jazz Pharmaceuticals – In-house Pipeline Products 19
    Table 10: Jazz Pharmaceuticals – Collaboration Pipeline Products 20
    Table 11: Jazz Pharmaceuticals – Historical Product Sales, 2002-2006 ($ Mn) 21
    Table 12: Jazz Pharmaceuticals – Forecast Sales, 2006-2010 ($ Mn) 22
    Table 13: Jazz Pharmaceuticals – Top Competitors 24
    Table 14: Jazz Pharmaceuticals – Key Suppliers 25
    Table 15: Jazz Pharmaceuticals – Key Clients 25
    Table 16: Jazz Pharmaceuticals - Key Shareholders 26
    Table 17: Jazz Pharmaceuticals - SWOT Analysis Summary 29
    Table 18: Jazz Pharmaceuticals – Value Chain Analysis 34
    Table 19: Jazz Pharmaceuticals - Scorecard 36
    Table 20: Jazz Pharmaceuticals - Key Employees 38
    Table 21: Jazz Pharmaceuticals - Financial and Operational Overview 47